| Moffitt

Can Adding Immunotherapy to Chemo Benefit More Cervical Cancer Patients?

Phase 3 trial results suggest adding pembrolizumab to chemotherapy improved survival for those with advanced or recurrent disease

Cell Therapy Superior to Standard of Care for Multiple Myeloma

Phase 3 trial results show improved response rate and reduced risk of disease progression

Treatment Innovations in Rectal, Lung and Brain Cancers

New research shows benefit of de-escalating and targeting therapies to improve outcomes

Adding Inhibitor to Hormonal Therapy Reduces Risk of Breast Cancer Recurrence

Phase 3 trial results could be practice changing for both men and women

New Study Shows Promise for Difficult to Treat Brain Metastases

First in human trial is recruiting patients with leptomeningeal disease from triple- negative or HER2 positive breast cancers

The Truth About Clinical Studies: The Most Advanced Cancer Care at Moffitt Cancer Center

Learn more about some common misconceptions that prevent patients from joining clinical trials.

Hematologist Trains at Moffitt, Hoping to Benefit Armenians

Through a visiting physician program, a doctor is learning the intricacies of an allogeneic BMT procedure and care to help his home country

Improving Cancer Care for People with HIV

Moffitt’s HIV clinic reduces burdens for patients fighting for their health on two fronts

Mobile Monitoring: Making Cancer Care More Accessible

Moffitt researchers and clinicians are taking telehealth to the next level

Global Clinical Trial Explores New Combination Therapy for Metastatic Breast Cancer

The ongoing VIKTORIA-1 Phase 3 trial targets patients with hormone receptor positive, HER2 negative breast cancer

Navigating Racial and Ethnic Criteria Appropriately Could Boost Clinical Trial Eligibility

According to researchers, criteria may pose additional barriers to minority cancer patients

CAR T Shows Promise for Adults with Acute Lymphoblastic Leukemia

Kids under 5 have the highest risk for ALL, but it’s more deadly in adults.

Phase 2 Bladder Cancer Trial Shows Promising Results

Updated data were presented at the 2022 SITC Annual Meeting

Combining Targeted Radiotherapy with Immunotherapy May Improve Outcomes for Cervical Cancer Patients

Interim results from phase 2 clinical trial reveal responses to combination therapy

World-Renowned Trumpeter Finds Hope in Merkel Cell Carcinoma Clinical Trial

Vince DiMartino has had a robust response rate to the combination treatment of two immunotherapy drugs

Moffitt Cancer Center’s Clinical Trials Focus on Expansion, Diversity and Innovation

The cancer center offers one of the largest portfolios of clinical trials in the nation, with nearly 400 active treatment trials

Moffitt Cancer Center Expanding to South Hillsborough County

New facility expected to serve thousands more patients and create 150 jobs

5 Questions on MRI Linac

Dr. Stephen Rosenberg discusses how MRI-guided radiation therapy is better personalizing treatment for each patient

TIL Therapy Shows Promise in Non-Small Cell Lung Cancer

Cellular therapy gave scuba diver Deborah Barker a new option for beating the disease

New Data May Change Approach to Treating Multiple Myeloma, Ewing Sarcoma and Breast Cancer

ASCO studies show benefit to reevaluating current standard of care for these diseases

Studies Highlight Optimizing Therapy in Colon and Breast Cancer

Better targeting treatment approaches can greatly reduce toxicities

Adding Ibrutinib to Standard of Care Improves Progression Free Survival in Older Patients with Mantle Cell Lymphoma

However, experts say it may be too soon to say new phase 3 trial data is practice changing

FDA Approves Radioactive Treatment for Prostate Cancer

Moffitt participated in landmark VISION trial for prostate-specific membrane antigen-positive metastatic castration-resistant disease

Ovarian Cancer: What You Need to Know

Moffitt experts answer your questions

Through 3D Printing, Breast Surgeons Can Better Target Cancer Tumors

Moffitt clinical trial uses a 3D mold of the breast to assist surgeons in the operating room

Do You Know the Facts About Sarcoma?

The rare, but treatable, type of cancer affects thousands of Floridians

Increasing Diversity in Clinical Trials

With less than 10% of minority cancer patients enrolled in trials, Moffitt is working to break down barriers and increase access to care

Can the Herpes Virus Fight Triple-Negative Breast Cancer?

More than 90% of women injected with the virus are alive up to three years later

FDA Approves CAR T to Help Patients with Relapsed Multiple Myeloma

For one patient, the therapy, made available to him through a clinical trial, was his last resort

Novel Bladder Cancer Trial Showing Promising Results

Trial uses oncolytic virus to treat muscle invasive bladder cancer

New CAR T Therapy Tested for Multiple Myeloma

The cellular targets the B-cell maturation antigen found on malignant plasma cells

CAR T Brings Hope for Leukemia Patients, Challenges for Researchers

Phase 1 THINK study laid important groundwork for future CAR T trials

New Combination Therapy Shows Promise for Leukemia Patients

Early phase trial finds magrolimab plus chemotherapy effective in acute myeloid leukemia patients

Once a Fighter, Always a Fighter

Former prosecutor battles stage 4 lung cancer with help of investigational immunotherapy

From the Battlefield to Battling Breast Cancer

Buccaneers honor local veteran and breast cancer survivor

Fluorescent Imaging Could be ‘Game Changer’ in Breast Cancer Surgery

Technique helped 3 out of 4 women avoid second surgeries, study shows

Clinical Trial Offers Hope for Mesothelioma Patients

Chemoperfusion therapy has shown to increase survival and quality of life

Speeding Up Cellular Immunotherapy

New ‘off the shelf’ CAR T product shows promise in phase 1 study

Melanoma Immunotherapy Offers Hope for Lung Cancer

Patients’ own magnified army of T cells used to treat non-small cell lung cancer

Clinical Trials and COVID-19

Majority of Moffitt patients receiving investigational therapies still on track

In the Eye of the COVID-19 Storm

How yearly hurricane planning helped Moffitt be prepared for the pandemic

Repurposing Drugs to Fight COVID-19

World Health Organization launches global trials on four possible treatments

Innovative Trial Tackles Early Stage Breast Cancer

Immunotherapy plus chemotherapy shows promising results for certain early stage breast cancers

Can Gene Editing Improve Cellular Immunotherapy?

New study suggests CRISPR edited cells can be used to enhance T cell receptor therapy

Moffitt Clinical Trials Offer Hope for Cervical Cancer Patients

“I’m living a normal life,” says one trial participant

Moffitt Launches Innovative Trial for Brain-Metastatic Breast Cancer

The therapy includes a three-part immunotherapy combination to shrink tumors.

The Power of CAR T in Solid Tumor Treatment

CAR T therapy involves a patient’s own T cells that have been genetically engineered to target a patient’s own specific cancer.

‘A Clinical Trial Saved My Life’

After melanoma metastasized to his brain, Larry Thomason was given 10 months to live.

Clinical Trial Brings Hope to Lung Cancer Patient

Last year, Lee was diagnosed with stage 4 metastatic lung cancer that had spread to her brain and spine.

Clinical Research and Patient Safety

As a National Cancer Institute-designated cancer center, Moffitt is charged with conducting investigator-initiated trials, which are designed and mana ...

Clinical Research Unit: A Source of Hope

Look in Moffitt’s Clinical Research Unit (CRU), and you’ll find it in the work of a united team doing whatever is necessary to transform hope into rea ...

Herpes Virus Can be Used to Treat Melanoma. Which Cancer is Next?

Since the approval of talimogene laherparepvec (T-VEC, Imlygic®) in 2015, Moffitt has been using this modified form of the herpes virus as a standard ...

Saving Lives After Death

Gail Porter was the first patient to enroll in Moffitt's rapid tissue donation program.

The Monkees’ Peter Tork Had Rare Tongue Cancer

The Monkees’ bassist passed away this week. He also had a rare form of tongue cancer.

Benefits of an Open Mind

Jhanelle E. Gray, MD, says she never dreamed she would be working at a faraway place like Tianjin, China.

Filter Features Results

55 Articles Found